Address
Novartis Venture Funds
Novartis International AG WSJ-200.220 P.O. Box
4002 Basel
Switzerland
Phone
Industry
Recent investment activity
KANDO id: 30987
Company type
The corporate venturing arm of Novartis.Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 49| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Alnylam Pharmaceuticals Inc | N/A | ||||
|
|
Anchor Therapeutics Inc | Series B | ||||
|
|
Ascent Therapeutics Inc | Series A | ||||
|
|
Autonomic Technologies Inc | N/A | ||||
|
|
Avila Therapeutics Inc | A biotechnology company, pioneering a method to discover and develop new small-molecule medicines that achieve 'protein silencing'. | N/A | |||
|
|
Biofisica Inc | Wound care company. | Series A | |||
|
|
Catalyst Biosciences Inc | Developer of catalytic biopharmaceutical products based on engineered human proteases. | Series C | |||
|
|
Catalyst Biosciences Inc | Developer of catalytic biopharmaceutical products based on engineered human proteases. | Series B | |||
|
|
Catalyst Biosciences Inc | Developer of catalytic biopharmaceutical products based on engineered human proteases. | Series A | |||
|
|
Celladon Corp | N/A | ||||
|
|
Cequent Pharmaceuticals | Series A | ||||
|
|
FoldRx Pharmaceuticals Inc | N/A | ||||
|
|
Forma Therapeutics Inc | N/A | ||||
|
|
Heptares Therapeutics Ltd | Series A | ||||
|
|
Intradigm Corp | Series B | ||||
|
|
Intradigm Corp | Series A | ||||
|
|
IRX Therapeutics Inc | N/A | ||||
|
|
LigoCyte Pharmaceuticals Inc | N/A | ||||
|
|
Lumenos Inc | Provider of consumer-driven health care plans. | N/A | |||
|
|
Nereus Pharmaceuticals Inc | N/A | ||||
|
|
Nereus Pharmaceuticals Inc | Series B | ||||
|
|
Okairos AG | N/A | ||||
|
|
Panomics Inc | Develops novel cell-based assays and tools to enable multiplexed measurements of molecular events in a quantitative and scalable manner | N/A | |||
|
|
PharmAbcine Inc | Develops fully human therapeutic monoclonal antibody (mAb) | Series A | |||
|
Portaero Inc | N/A |
Team
| Employee | Position | |||
|---|---|---|---|---|
| Florent Gros | [email protected] | |||
| Rudolf Gygax | [email protected] |